Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma (COMMAND)
This study has been terminated.
(Interim analysis-DSMB stated good safety profile but lack of efficacy)
First Posted: June 6, 2013
Last Update Posted: January 30, 2017
Information provided by (Responsible Party):